These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 36279032
1. Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas. Araujo-Castro M, García Cano AM, Escobar-Morreale HF, Valderrabano P. Hormones (Athens); 2023 Mar; 22(1):51-59. PubMed ID: 36279032 [Abstract] [Full Text] [Related]
2. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas? Araujo-Castro M, Hanzu FA, Pascual-Corrales E, García Cano AM, Marchan M, Escobar-Morreale HF, Valderrabano P, Casals G. Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760 [Abstract] [Full Text] [Related]
3. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas. Araujo-Castro M, Parra Ramírez P, Robles Lázaro C, García Centeno R, Gracia Gimeno P, Fernández-Ladreda MT, Sampedro Núñez MA, Marazuela M, Escobar-Morreale HF, Valderrabano P. Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083 [Abstract] [Full Text] [Related]
4. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL. Araujo-Castro M, Parra Ramírez P, Martín Rojas-Marcos P, García Centeno R, Gracia Gimeno P, Tomé Fernández-Ladreda M, Sampedro Núñez MA, Higueruela C, Robles Lázaro C. Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701 [Abstract] [Full Text] [Related]
5. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas. Araujo-Castro M, Robles Lázaro C, Parra Ramírez P, García Centeno R, Gracia Gimeno P, Fernández-Ladreda MT, Sampedro Núñez MA, Marazuela M, Escobar-Morreale HF, Valderrabano P. J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661 [Abstract] [Full Text] [Related]
6. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences? Araujo-Castro M, Robles Lázaro C, Parra Ramírez P, Cuesta Hernández M, Sampedro Núñez MA, Marazuela M. Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918 [Abstract] [Full Text] [Related]
7. Predictors of Tumour Growth and Autonomous Cortisol Secretion Development during Follow-Up in Non-Functioning Adrenal Incidentalomas. Araujo-Castro M, Parra Ramírez P, Robles Lázaro C, García Centeno R, Gracia Gimeno P, Fernández-Ladreda MT, Sampedro Núñez MA, Marazuela M, Escobar-Morreale HF, Valderrabano P. J Clin Med; 2021 Nov 25; 10(23):. PubMed ID: 34884211 [Abstract] [Full Text] [Related]
8. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study. Falcetta P, Orsolini F, Benelli E, Agretti P, Vitti P, Di Cosmo C, Tonacchera M. Endocrine; 2021 Jan 25; 71(1):178-188. PubMed ID: 32915435 [Abstract] [Full Text] [Related]
9. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center. Patrova J, Kjellman M, Wahrenberg H, Falhammar H. Endocrine; 2017 Nov 25; 58(2):267-275. PubMed ID: 28887710 [Abstract] [Full Text] [Related]
10. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study. Remde H, Kranz S, Morell SM, Altieri B, Kroiss M, Detomas M, Fassnacht M, Deutschbein T. Front Endocrinol (Lausanne); 2023 Nov 25; 14():1123132. PubMed ID: 37223045 [Abstract] [Full Text] [Related]
11. Diagnostic accuracy of the different hormonal tests used for the diagnosis of autonomous cortisol secretion. Araujo-Castro M, García Cano A, Jiménez Mendiguchía L, Escobar-Morreale HF, Valderrábano P. Sci Rep; 2021 Oct 15; 11(1):20539. PubMed ID: 34654835 [Abstract] [Full Text] [Related]
12. Performance of DHEAS as a Screening Test for Autonomous Cortisol Secretion in Adrenal Incidentalomas: A Prospective Study. Liu MS, Lou Y, Chen H, Wang YJ, Zhang ZW, Li P, Zhu DL. J Clin Endocrinol Metab; 2022 Apr 19; 107(5):e1789-e1796. PubMed ID: 35137142 [Abstract] [Full Text] [Related]
13. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk. Di Dalmazi G, Fanelli F, Zavatta G, Ricci Bitti S, Mezzullo M, Repaci A, Pelusi C, Gambineri A, Altieri P, Mosconi C, Balacchi C, Golfieri R, Cosentino ER, Borghi C, Vicennati V, Pasquali R, Pagotto U. J Clin Endocrinol Metab; 2019 Nov 01; 104(11):5519-5528. PubMed ID: 31381072 [Abstract] [Full Text] [Related]
14. Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up. Yener S, Baris M, Peker A, Demir O, Ozgen B, Secil M. Clin Endocrinol (Oxf); 2017 Nov 01; 87(5):425-432. PubMed ID: 28656620 [Abstract] [Full Text] [Related]
15. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy. Vieira-Correa M, Giorgi RB, Oliveira KC, Hayashi LF, Costa-Barbosa FA, Kater CE. J Endocrinol Invest; 2019 Dec 01; 42(12):1435-1442. PubMed ID: 31456173 [Abstract] [Full Text] [Related]
16. Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: a study of 709 cases. Brox-Torrecilla N, García Cano AM, Valderrábano P, Quintero Tobar A, Escobar-Morreale HF, Araujo-Castro M. Endocrine; 2023 Sep 01; 81(3):484-491. PubMed ID: 37212980 [Abstract] [Full Text] [Related]
17. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Deutschbein T, Reimondo G, Di Dalmazi G, Bancos I, Patrova J, Vassiliadi DA, Nekić AB, Debono M, Lardo P, Ceccato F, Petramala L, Prete A, Chiodini I, Ivović M, Pazaitou-Panayiotou K, Alexandraki KI, Hanzu FA, Loli P, Yener S, Langton K, Spyroglou A, Kocjan T, Zacharieva S, Valdés N, Ambroziak U, Suzuki M, Detomas M, Puglisi S, Tucci L, Delivanis DA, Margaritopoulos D, Dusek T, Maggio R, Scaroni C, Concistrè A, Ronchi CL, Altieri B, Mosconi C, Diamantopoulos A, Iñiguez-Ariza NM, Vicennati V, Pia A, Kroiss M, Kaltsas G, Chrisoulidou A, Marina LV, Morelli V, Arlt W, Letizia C, Boscaro M, Stigliano A, Kastelan D, Tsagarakis S, Athimulam S, Pagotto U, Maeder U, Falhammar H, Newell-Price J, Terzolo M, Fassnacht M. Lancet Diabetes Endocrinol; 2022 Jul 01; 10(7):499-508. PubMed ID: 35533704 [Abstract] [Full Text] [Related]
18. Adrenal incidentaloma as a novel independent predictive factor for periodontitis. Rodrigues MO, Moraes AB, de Paula MP, Pereira VA, Leão ATT, Vieira Neto L. J Endocrinol Invest; 2021 Nov 01; 44(11):2455-2463. PubMed ID: 33788166 [Abstract] [Full Text] [Related]
19. Impaired Cognitive Function in Patients With Autonomous Cortisol Secretion in Adrenal Incidentalomas. Liu MS, Tian ZY, Zhang Z, Yang F, Lou Y, Wang YJ, Zeng YJ, Zhang ZW, Zhu DL, Li P. J Clin Endocrinol Metab; 2023 Feb 15; 108(3):633-641. PubMed ID: 36263685 [Abstract] [Full Text] [Related]
20. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM. Eur J Endocrinol; 2016 Aug 15; 175(2):G1-G34. PubMed ID: 27390021 [Abstract] [Full Text] [Related] Page: [Next] [New Search]